Skip to main content
Population screening programmes

Research and statistics

105 results that are All research and statistics, sorted by Updated (newest)
  • Data report for abdominal aortic aneurysm (AAA) screening for 1 April 2020 to 31 March 2021.

  • Screening data for the NHS sickle cell and thalassaemia (SCT) screening programme for the year 1 April 2019 to 31 March 2020.

  • Findings of research working towards an international consensus on principles for the provision of evidence-based screening information.

  • Summary of systematic evidence review of interventions to improve participation in UK national screening programmes among underserved groups.

  • Breast screening pathology audit for the screening period April 2016 to March 2019.

  • Data report for fetal anomaly screening, infectious diseases in pregnancy screening and sickle cell and thalassaemia screening 1 April 2019 to 31 March 2020.

  • Screening data for the NHS sickle cell and thalassaemia (SCT) screening programme for the year 1 April 2018 to 31 March 2019.

  • Key performance indicator (KPI) data reports for NHS population screening programmes for financial year 2019 to 2020.

  • Data report for abdominal aortic aneurysm screening for 1 April 2019 to 31 March 2020.

  • Data report for fetal anomaly screening, infectious diseases in pregnancy screening and sickle cell and thalassaemia screening 1 April 2018 to 31 March 2019.

  • This report provides information on the pilot to allow experienced assistant practitioners (APs) to work on mobile vans or remote static sites.

  • Executive summary of quality assurance (QA) visit to the Hereford and Worcester NHS abdominal aortic aneurysm screening programme on 3 March 2020.

  • Data for the NHS sickle cell and thalassaemia screening programme for the year 1 April 2017 to 31 March 2018.

  • Joint data report for fetal anomaly screening, infectious diseases in pregnancy screening and sickle cell and thalassaemia screening 1 April 2017 to 31 March 2018.

  • Report on cervical screening programme standards in England including trend data where available.

  • Key performance indicator (KPI) data reports for NHS population screening programmes for financial year 2018 to 2019.

  • Series of 2018 to 2019 data tables and reports for the local abdominal aortic aneurysm screening programmes in England.

  • Executive summary of quality assurance (QA) visit to the NHS diabetic eye screening programme in Northamptonshire held on 13 June 2019.

  • This audit report provides data on cases of invasive cervical cancer from 1 April 2013 to 31 March 2016.

  • The report briefly defines genome sequencing and how, by improving our understanding of genetic activity, we can determine how best to use genetics in screening.